The study shows ligustilide can reverse oxidative stress-induced BNIP3 downregulation, but the molecular pathway by which ligustilide counteracts ROS effects on BNIP3 expression is not mechanistically explained. This gap limits rational drug design and optimization of mitophagy-enhancing therapies. Gap type: unexplained_observation Source paper: Enhancing mitophagy by ligustilide through BNIP3-LC3 interaction attenuates oxidative stress-induced neuronal apoptosis in spinal cord injury. (2024, International journal of biological sciences, PMID:39247814)
Landscape Summary: How does ligustilide specifically reverse ROS-induced BNIP3 downregulation? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does ligustilide specifically reverse ROS-induced BNIP3 downregulation? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: